CDC Newsroom

ShareCompartir

This page is a historical archive and is no longer maintained.

For current information, please visit http://www.cy118119.com/media/

Media Advisory

For Immediate Release: Monday, October 21, 2013
Contact: Media Relations
(404) 639-3286

CDC's Advisory Committee on Immunization Practices Meeting

Please Note the Need to RSVP

What

Meeting of the Advisory Committee on Immunization Practices (ACIP)

When

Wednesday, October 23; 8:00 am - 5:45 pm ET
Thursday, October 24; 8:00 am a€“ 1:00 pm ET

Where

Centers for Disease Control and Prevention
1600 Clifton Road NE
Atlanta, GA 30329

Tom Harkin Global Communications Center (Building 19), Kent a€?Oza€? Nelson Auditorium

For directions to CDC, please visit http://www.cy118119.com/about/resources/visitGuide.htm#direction

Webstream

If you cannot attend the meeting in person, it will be web streamed. More information can be found at http://www.cy118119.com/vaccines/acip/meetings/webcast-instructions.html

Background

An agenda for the meeting can be found at http://www.cy118119.com/vaccines/recs/acip/. The agenda will include three votes: considerations for use of meningococcal conjugate vaccine MenACWY-CRM in infants and young toddlers at increased risk for meningococcal disease; the 2014 Child/Adolescent Immunization Schedule; and the 2014 Adult Immunization Schedule. Both the child/adolescent and adult immunization schedules are updated annually. The 2014 adult immunization schedule incorporates changes approved by the ACIP during the 2013 calendar year.

The Advisory Committee on Immunization Practices (ACIP) consists of 15 experts in fields associated with immunization who have been selected by the Secretary of the U.S. Department of Health and Human Services to provide advice and guidance to the Secretary and the Assistant Secretary for Health, and the Director of the Centers for Disease Control and Prevention (CDC) on control of vaccine-preventable diseases. The Committee develops written recommendations for use of vaccines that are licensed in the United States; considerations include age for vaccine administration, number of doses and dosing interval, safety issues, and precautions and contraindications.

Special Note

Reporters who wish to attend the meeting in person must send RSVP to Jamila Jones, press officer, CDC's Division of Public Affairs, at jhoward2@cdc.gov or contact CDCa€?s main press office at 404-639-3286 by noon on Tuesday, October 22. Space is limited, and only those reporters who RSVP will be guaranteed working space during the meeting.

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES